Molecular Classification of Colorectal Cancer
نویسنده
چکیده
...................................................................................................................... 9 REVIEW OF THE LITERATURE .............................................................................. 11 1. GENES AND CANCER...........................................................................................................................11 1.1 Oncogenes............................................................................................................................................12 1.2 Tumor suppressor genes ......................................................................................................................13 1.2.1 Gatekeepers.................................................................................................................................13 1.2.2 Caretakers....................................................................................................................................13 1.2.3 Landscapers..................................................................................................................................13 1.3 Epigenetic mechanisms .......................................................................................................................14 1.3.1 Methylation ..................................................................................................................................14 1.3.2 Loss of imprinting (LOI) .............................................................................................................14 2. COLORECTAL CANCER......................................................................................................................15 2.1 Non-polyposis syndromes ...................................................................................................................15 2.2 Polyposis syndromes ...........................................................................................................................17 2.2.1 Adenomatous polyposis syndromes.............................................................................................17 2.2.2 Hamartomatous polyposis syndromes .........................................................................................18 2.3 Low-penetrance alleles predisposing to colorectal cancer ..................................................................19 3. PATHWAYS LEADING TO COLORECTAL CANCER...................................................................19 3.1 Suppressor pathway (The adenoma-carcinoma sequence)..................................................................19 3.2 Mutator pathway ..................................................................................................................................22 3.3 Serrated neoplasia pathway .................................................................................................................23 4. MICROSATELLITE INSTABILITY....................................................................................................24 4.1 Mismatch repair system.......................................................................................................................26 4.1.1 Defects in mismatch repair system ..............................................................................................28 AIMS OF THE STUDY ................................................................................................. 30 MATERIALS AND METHODS ................................................................................... 31 1. PATIENT SAMPLES (I, II, III, IV) .......................................................................................................31 1.1 DNA (I, II, III, IV) and RNA (IV) extraction......................................................................................31 2. MSI ANALYSIS (I, II) .............................................................................................................................31 3. IMMUNOHISTOCHEMISTRY AND MUTATION ANALYSIS OF MLH1, MSH2 AND MSH6 (I) ........................................................................................................................................................................32 4. LOCUS SPECIFIC LOH ANALYSIS (II).............................................................................................32 5. MUTATION ANALYSIS OF KRAS (II)................................................................................................34 6. MGMT, MLH1, AND EPHB2 PROMOTER HYPERMETHYLATION ANALYSIS (II, IV).........34 6.1 Bisulfite modification ..........................................................................................................................34 6.2 Methylation specific PCR....................................................................................................................34 7. TOPOGRAPHIC MUTATION HETEROGENEITY ANALYSIS (II)..............................................35 8. ALLELIC IMBALANCE (AI) ANALYSIS (III) ..................................................................................35 9. COMPARATIVE GENOMIC HYBRIDIZATION (CGH) (III).........................................................36 10. REAL–TIME QUANTITATIVE PCR.................................................................................................36 11. STATISTICAL ANALYSES (II, III) ...................................................................................................36
منابع مشابه
Consensus Molecular Subtypes of Colorectal Cancer and their Clinical Implications
The colorectal cancer (CRC) subtyping consortium has unified six independent molecular classification systems, based on gene expression data, into a single consensus system with four distinct groups, known as the consensus molecular subtypes (CMS); clinical implications are discussed in this review based on articles relevant to the CMS of CRC indexed in PubMed as well as the authors’ own ...
متن کاملPromoter hypermethylation of KLOTHO; an anti-senescence related gene in colorectal cancer patients of Kashmir valley
Hypermethylation of CpG islands located in the promoter regions of genes is a major event in the development of the majority of cancer types, due to the subsequent aberrant silencing of important tumor suppressor genes. KLOTHO; a novel gene associated primarily with suppressing senescence has been shown to contribute to tumorigenesis as a result of its impaired function. Recently the relevance ...
متن کاملThe Role of Cyclooxygenase-2 in Signaling Pathways Promoting Colorectal Cancer
Colorectal cancer is one of the most common cancers in the world. Various factors are involved in the development and progression of this disease. One of these agents is cyclooxygenase-2 (COX-2). COX-2 is a product of the PTGS2 gene and converts free arachidonic acid to prostaglandins. COX-2 is not naturally expressed in most normal cells. Noticeably, the increased expression of COX-2 has been ...
متن کاملResistin and Visfatin Expression in HCT-116 Colorectal Cancer Cell Line
Adipocytokines, hormones secreted from adipose tissue, have been shown to be associated with many cancers such as breast, prostate and colorectal cancer. Recent studies have indicated that resistin and visfatin, two of these adipokines have high level plasma concentrations in colorectal cancer patients and may be promising biomarkers for colorectal cancer. The aim of this study was to identify ...
متن کاملThe Role of Angiogenesis in Colorectal Polyps and Cancer, a Review
ABSTRACT Colorectal cancer remains a leading cause of morbidity and mortality worldwide. Most colorectal cancers begin as a growth of tissue called a polyp, some types of which can change into cancer over the course of several years. Angiogenesis, the formation of new blood vessels, is known to play a key role in the initiation, growth and...
متن کاملInvestigating the biomarker role of piRNAs in the diagnosis of colorectal cancer
Background & objectives: Colorectal cancer (CRC) is the most common gastric cancer and third lethal cancer worldwide. Despite development in diagnostic and treatment methods, due to the lack of typical symptoms in the early stages, most patients are diagnosed in the end stages. Therefore, finding simple, inexpensive, highly sensitive and specific diagnostic methods for early detection and prog...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2005